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Communication Impairments in People with Progressive Supranuclear Palsy: A Tutorial 
1. Introduction 
Five decades ago, Steele, Richardson, and Olszewski (1964) described an unusual clinical and 
neuropathological profile of nine patients with a progressive neurological condition displaying 
supranuclear gaze palsy, axial rigidity, dysarthria, pseudobulbar and mental signs with mild 
subcortical dementia. Although some case reports of a similar combination of the clinical symptoms 
can be found in the neurological literature much earlier, Steele et al. (1964) is credited with 
establishing this syndrome as a new nosological entity; progressive supranuclear palsy (PSP) (also 
known as Steele-Richardson-Olszewski syndrome). Over the subsequent decades, numerous clinical, 
neuropathological and genetic studies have been conducted and, recently, there has been a new surge 
of interest in PSP from clinical neuropsychology (e.g. Duff, Gerstenecker, & Litvan, 2013; 
Gerstenecker, Mast, Duff, Ferman, & Litvan, 2013; Kobylecki et al., 2015), movement disorders (e.g. 
Kemp, Harding, Halliday, Mahant, & Fung, 2013; Respondek et al., 2013) and nursing (e.g. Kent, 
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2013; Mazorra & Cadogan, 2012). On the other hand, PSP has received comparatively, and 
significantly, less attention in the speech-language pathology literature, even though communication 
impairments in patients with PSP have been documented since the initial publication of Steele et al. 
(1964). So far, the majority of the findings relating to speech and language impairments in people 
with PSP have come from studies in clinical neuropsychology, in which speech and/or language 
assessments were administered as part of their assessment battery. In the absence of any current 
guidelines for the assessment and management of communication impairments in people with PSP, 
speech-language pathologists (SLPs) are reliant on the descriptions provided by a neuropathological 
perspective. The purposes of this tutorial paper are (1) to describe the communication impairments in 
people with PSP, (2) to inform SLPs of areas for assessment, and (3) to present treatment 
considerations. 
 
2. Overview of Progressive Supranuclear Palsy 
PSP is a rare progressive neurological disorder with the age-adjusted prevalence estimated at 6.4 per 
100,000 (Schrag, Ben-Shlomo, & Quinn, 1999). While individual presentations vary greatly, 
supranuclear gaze palsy, frequent falls (usually backwards), bradykinesia, axial rigidity, cognitive 
decline and communication impairments are the most commonly reported characteristics of PSP 
(Donker Kaat, Boon, Kamphorst, Duivenvoorden, & van Swieten, 2007; Nath, Ben-Shlomo, 
Thomson, Lees, & Burn, 2003; Testa et al., 2001). The initial symptoms of PSP typically emerge after 
the age of 60 years (Donker Kaat et al., 2007; Nath et al., 2003), with no studies reporting the onset of 
symptoms before the age of 40 years. PSP was considered a sporadic disease with no known cause, 
but recent studies have suggested possible familial aggregation (e.g. Donker Kaat et al., 2009; Pastor, 
2009; Pastor et al., 2001). 
Pathologically, the most specific microscopic findings of PSP are star-shaped astrocytic tufts 
and neurofibrillary tangles found in the basal ganglia, diencephalon and brainstem (Dickson, Ahmed, 
Algom, Tsuboi, & Josephs, 2010; Donker Kaat, Chiu, Boon, & van Swieten, 2011; Hauw et al., 1994; 
Williams & Lees, 2009). Gliosis and neuronal loss have also been documented widely (Dickson et al., 
2010 for a review). The subthalamic nucleus, substantia nigra and globus pallidus are most severely 
Page 3 of 30
Ac
ce
pte
d M
an
us
cri
pt
  3 
affected (Dickson et al., 2010; Donker Kaat et al., 2011; Hauw et al., 1994). Atrophy and the presence 
of neurofibrillary tangles have also been found in the frontal regions while parietal and temporal 
regions are relatively unaffected by PSP (Donker Kaat et al., 2011).  
 
2.1. Clinical Diagnosis 
Despite the advancement in the field of clinicopathology, no reliable biological markers for the ante-
mortem diagnosis of PSP have been identified. Definite diagnosis of PSP requires histological 
evidence, only available post-mortem (Litvan et al., 1996). Clinical diagnosis of PSP requires a 
detailed case history and accurate interpretation of behavioral assessments. To improve the specificity 
and sensitivity of the diagnosis of PSP during life, the National Institute of Neurological Disorders 
and Stroke and the Society for PSP (NINDS-SPSP) proposed criteria for the clinical diagnosis of PSP 
(Litvan et al., 1996). Two types of clinical diagnosis were proposed; “Possible” and “Probable”. 
Possible diagnosis requires the following criteria: (1) gradual progression of the disease, (2) onset at 
the age of 40 years or later, (3) either vertical supranuclear gaze palsy or both slowing of vertical 
saccades and prominent postural instability with falls in the first year of disease onset, and (4) no 
evidence of other diseases that could explain the foregoing features. The criteria for a Probable 
diagnosis requires (1)  gradual progression of the disease, (2)  onset after the age of 40 years (3) both 
vertical supranuclear gaze palsy and prominent postural instability with falls in the first year of 
disease onset, and (4) no evidence of other diseases. In addition, the presence of symmetric akinesia, 
rigidity (proximal more than distal), abnormal neck posture, early dysphagia and dysarthria, and early 
onset of cognitive impairments (including apathy, impairment in abstract thought, decreased verbal 
fluency, frontal release signs) and poor or absent response to levodopa treatment can support the 
clinical diagnosis of PSP (Litvan et al., 1996). 
The sensitivity and predictive values of the criteria proposed by NINDS-SPSP have been 
supported (Osaki et al., 2004; Respondek et al., 2013; Williams et al., 2005). However, clinical 
diagnosis of PSP still remains difficult. This is largely because clear signs only emerge in its later 
stages for the majority of people. The absence of hallmark symptoms of PSP, along with the presence 
of other symptoms (e.g. bradykinesia, cognitive impairments, speech/language impairments) in its 
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early stages often leads to patients being misdiagnosed with Parkinson’s disease (PD), dementia, 
multiple system atrophy or corticobasal degeneration (Donker Kaat et al., 2007; Nath et al., 2003; 
Williams et al., 2005). It can take up to five years and multiple visits to different physicians before the 
accurate diagnosis of PSP is made for many people (O'Sullivan et al., 2008; Santacruz, Uttl, Litvan, & 
Grafman, 1998). The disease duration is estimated at between five and eight years (Chiu et al., 2010; 
Donker Kaat et al., 2007; O'Sullivan et al., 2008; Papapetropoulos, Singer, McCorquodale, Gonzalez, 
& Mash, 2005; Williams et al., 2005), with the most common causes of death being respiratory 
infection, respiratory failure, aspiration pneumonia and cardiopulmonary failure (Nath et al., 2005; 
Papapetropoulos et al., 2005). This suggests that with a predominant focus on respiratory and 
swallowing dysfunction, the motor speech and language impairments may be overlooked and many 
patients remain under-diagnosed during the course of the disease progression. 
 
2.2. Heterogeneity 
Initially, Steele et al. (1964, p. 357) reported “no pathological evidence of frontal, cortical, or white 
matter involvement of consequence”. However, subsequent studies have reported mild atrophy and 
the presence of neurofibrillary tangles in the frontal regions (Dickson et al., 2010) and there has been 
an increasing number of studies reporting atypical PSP, in which the patients display distinguishable 
clinical features with the underlying pathology characterized by the presence of neurofibrillary tangles 
(Williams & Lees, 2009). These atypical PSP cases do not necessarily meet the clinical criteria for the 
diagnosis proposed by the NINDS-SPSP. For example, patients with PSP (pathologically confirmed 
cases) whose main symptoms are progressive non-fluent aphasia and apraxia of speech (PSP-
Progressive nonfluent aphasia) have a more prominent cortical pathological distribution compared to 
typical PSP (PSP-Richardson’s syndrome) (Josephs et al., 2005; Josephs et al., 2006). Patients who 
have PSP with PD-like characteristics, including asymmetric onset, tremor, early bradykinesia and a 
positive response to levodopa treatment (PSP-Parkinsonism), have a less severe and more restricted 
pathological distribution than typical PSP (Williams et al., 2005). This suggests some heterogeneity 
within PSP, and the common variants are summarized in Table 1 (Donker Kaat et al., 2011; Williams 
& Lees, 2009). 
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Table 1. Variants of Progressive Supranuclear Palsy 
Variants  Clinical presentations 
PSP-Richardson’s syndrome* Early falls and postural instability 
 
Early supranuclear gaze palsy 
 
Early cognitive decline 
PSP-Parkinsonism Asymmetric onset 
 
Positive levodopa response 
 Early bradykinesia 
  Tremor 
PSP-Pure akinesia with gait  Gradual onset of freezing of gait or speech 
freezing Micropraphia and hypophonia 
 
No tremor 
 
No sustained response to levodopa 
 
No dementia, rigidity and gaze palsy in the first five years 
PSP-Progressive nonfluent 
aphasia 
Progressive speech and language impairments (apraxia of speech 
and nonfluent aphasia) 
PSP-Corticobasal syndrome Asymmetric dystonia 
 
Apraxia 
 
Alien limb syndrome 
  Cortical sensory loss 
* PSP-Richardson’s syndrome is considered typical PSP 
 
3. Speech and Language Impairments in People with Progressive Supranuclear Palsy 
This section describes the speech and language impairments of typical PSP. It is worth noting that the 
classification of PSP into different variants is a recent development and, therefore, not all studies 
report the variant(s) of PSP. Readers are directed to Josephs and Duffy (2008) and Duffy, Strand, and 
Josephs (2014) for recent reviews of PSP-Progressive apraxia of speech and/or nonfluent aphasia 
(PSP-PNFA).  
 
3.1. Speech Impairments: Dysarthria, Stuttering, Palilalia and Echolalia  
Dysarthria is one of the most common and prominent manifestations of typical PSP (Donker Kaat et 
al., 2007; Kluin, Foster, Berent, & Gilman, 1993; Kluin et al., 2001; Litvan et al., 1996; Nath et al., 
2003; Podoll, Schwarz, & Noth, 1991; Testa et al., 2001). Patients with PSP are affected by dysarthria 
in its early stages and for many people this can eventually become anarthria (Kluin et al., 2001; Steele 
et al., 1964). Cohort studies have identified a combination of the hypokinetic, spastic and ataxic 
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subtypes of dysarthria in patients with typical PSP (Hartelius, Gustavsson, Åstrand, & Holmberg, 
2006; Kluin et al., 1993; Kluin et al., 2001; Skodda, Visser, & Schlegel, 2011), but the ataxic 
component is less frequent (Kluin et al., 2001; Skodda et al., 2011). Müller et al. (2001) reported that 
imprecise or slurred articulation was the most prominent speech characteristic in patients with PSP. 
Hypophonia, monotonous and slow speech with reduced stress/intonation, reduced respiratory support 
for speech and inappropriate silences have also been noted in patients with PSP (Hartelius et al., 2006; 
Skodda et al., 2011). There are relatively few studies reporting the speech characteristics of people 
with different variants of PSP. One such study, comparing typical PSP and PSP-Parkinsonism (PSP-
P), found no significant differences in their speech characteristics (Skodda et al., 2011). 
PSP is often misdiagnosed as PD especially in its early stages (e.g. Donker Kaat et al., 2007). 
Early involvement of SLPs is pertinent in order to minimize the risk of misdiagnosis. When the motor 
speech assessment of a patient with a clinical diagnosis of PD reveals dysarthria other than the 
hypokinetic subtype, then SLPs should query the clinical diagnosis of PD. In cases where spastic or 
ataxic components are present, PSP is a likely alternative diagnosis (Duffy, 2013). Early onset of 
dysarthria can also contribute to the differential diagnosis. From the onset of the initial symptoms, the 
average latency to the development of dysarthria is 24 months in patients with PSP but 84 months in 
patients with PD (Müller et al., 2001). Nath et al. (2003) also note that some patients with PSP may 
have “speech problems” even at disease onset. Regular monitoring by SLPs is required because, 
compared to PD, dysarthria in patients with PSP tends to be more severe, develop earlier and progress 
more rapidly (Goetz, Leurgans, Lang, & Litvan, 2003; Hartelius et al., 2006; Müller et al., 2001; 
Skodda et al., 2011). 
Stuttering and palilalia are not uncommon in PSP (Kluin et al., 1993; Lebrun, Devreux, & 
Jousseau, 1986; Nath et al., 2003; Testa et al., 2001). Palilalia is characterized by compulsive 
repetitions of utterances (Christman, Boutsen, & Buckingham, 2004; LaPointe & Horner, 1981). 
Stuttering and palilalia are associated with the presence of hypokinetic dysarthria (Duffy, 2013). They 
tend to develop relatively late in the disease progression although a small number of cases have 
documented the presence of palilalia at disease onset (Nath et al., 2003). Lebrun et al. (1986, p. 248) 
reported a case study of a 55-year-old male with a clinical diagnosis of PSP whose initial symptoms 
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included “speech difficulties resembling stuttering”, but the case report of their language assessment 
appears to be more consistent with palilalia. While, according to Kluin et al. (1993), stuttering is more 
common in PSP than palilalia, a description of stuttering in patients with PSP is scarce in the literature. 
In a small number of studies, echolalia has also been reported (Delia Sala & Spinnler, 1998; 
Esmonde, Giles, Xuereb, & Hodges, 1996; Robinson, Shallice, & Cipolotti, 2006), but this is not a 
common feature of PSP (Donker Kaat et al., 2007; Nath et al., 2003; Testa et al., 2001). Delia Sala 
and Spinnler (1998) provide the most comprehensive account of echolalia in PSP. They reported a 52-
year-old female with a two-year history of progressive slowness, who was initially misdiagnosed with 
PD. Incessant echolalia was noted during a neurological examination two years post-onset. When 
tested eight months later, all her responses were echolalic, which rendered formal assessments 
impossible. Delia Sala and Spinnler (1998, p. 159) reported that her echolalic responses were not 
driven by the need to communicate but reflected “sheer immediate repetition of the last two to four 
words, sometimes short sentences, spoken by others”. 
 
3.2. Language Impairments 
Language impairments in PSP appear to be less common than motor speech impairments, but this 
may be because the importance of language impairments has been somewhat overlooked. Early 
studies reported only mild language impairments (e.g. Maher, Smith, & Lees, 1985) or found “no 
primary language changes in [PSP]” (Podoll et al., 1991, p. 1470). More recent studies, however, 
challenge the nature of the language impairments in PSP.  
3.2.1. Comprehension 
Early studies reported no comprehension difficulties in patients with PSP (Delia Sala & Spinnler, 
1998; Lebrun et al., 1986; Maher et al., 1985). However, in such studies, language comprehension 
was not systematically investigated but relied only on observations. More recent research has 
suggested that people with PSP have intact single-word comprehension (Esmonde et al., 1996; 
Robinson et al., 2006), but Podoll et al. (1991) found that five of their six patients had a 
comprehension impairment at the single-word level. Studies where comprehension has been 
systematically investigated reveal specific patterns of impairment with action-verbs and sentences 
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(Bak et al., 2006; Daniele et al., 2013; Daniele, Giustolisi, Silver, Colosimo, & Gainotii, 1994; 
Esmonde et al., 1996; Kemmerer & Hershey, 1996; Podoll et al., 1991). Due to the rapid progression 
of the disease it is important for SLPs to assess and monitor both the single word and sentence level 
comprehension of people with PSP.  
3.2.2. Single Word Production 
Table 2 summarizes studies of word finding difficulties which are the most frequently reported 
aspect of language impairment in patients with PSP. It is noted that verbal fluency and picture naming 
are conceptually different tasks requiring different cognitive and linguistic skills, whereby verbal 
fluency requires linguistic and cognitive ability, while naming draws predominantly on linguistic 
ability. Evidence so far suggests that naming performance is influenced by impairments in 
visuospatial processing, initiation, verbal semantic memory, word-search strategies, and retrieval 
processes, reflecting damage in the frontal cortex and/or frontostriatal circuits (Gurd & Hodges, 1997; 
Milberg & Albert, 1989; Podoll et al., 1991; Rosser & Hodges, 1994; van der Hurk & Hodges, 1995). 
The presence and the extent of such impairments appears to be associated with disease progression, 
but to date, no unified clinical description of naming impairments in PSP has emerged. 
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Table 2.  Single word production in progressive supranuclear palsy 
Task Study Assessments used Findings 
Verbal 
Fluency 
Bak et al. (2006) Letter and category Impaired  
 
Daniel et al. (1994)* NS
1 
Impaired  
 
Daniel et al. (2013) Letter and category Impaired  
 
Delia Sala & Spinnler 
(1998) 
NS Impaired  
 
Esmonde et al. (1996) Letter and category Impaired and progressively declined over time 
 
Gurd & Hodges (1997) Category only Impaired 
 
Lebrun et al. (1986) NS Impaired 
 
Maher et al. (1985) Letter only Seven of 10 patients failed (i.e. named fewer than 14 words in 
90 seconds) 
 
Milberg & Albert 
(1989) 
NS Impaired 
 
Robinson et al. (2006) Letter and category Impaired 
 
Rosser & Hodges 
(1994) 
Letter and category Impaired and more pronounced impairment in letter verbal 
fluency task 
Confrontation 
Naming 
Bak et al. (2006) Graded Naming Test
2
; 
Noun and Verb Naming
3 
Impaired performance on Graded Naming Test and more 
pronounced impairment in naming action verbs than nouns 
 
Cotelli et al. (2006) 60 actions and 60 objects More pronounced impairment in naming action verbs than 
nouns but no difference in naming performance between 
manipulation and non-manipulation action verbs 
 
Daniel et al. (1994)* Oral Confrontation 
Naming
4 
Selective impairment in naming verbs 
 
Daniel et al. (2013) Oral and Written
5
 
Confrontation Naming 
Impaired performance in naming verbs on both tasks 
 
Delia Sala & Spinnler 
(1998) 
Aachen Aphasia Test
6
 
(Italian version) 
Moderate impairment 
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Esmonde et al. (1995) NS picture naming Normal or near normal naming performance 
 
Gurd & Hodges (1997) Speeded Picture Naming
7 
Considerable slowing in picture naming 
 
Lebrun et al. (1986) NS  Normal performance 
 
Maher et al. (1985) Graded Naming Test
2 
Mild word finding difficulty in seven of 25 patients 
 
Milberg & Albert 
(1989) 
Boston Naming Test
8 
Impaired but less pronounced than verbal fluency impairment 
 
Podoll et al. (1991) Aachen Aphasia Test
6
 
(Object and Color 
Naming subtests) 
Mild word finding difficulty in two of six patients 
 
Robinson et al. (2006) Category Naming Test
9 
Normal performance and no difference in naming performance 
between action verbs and nouns 
  
van der Hurk & Hodges 
(1995) 
Boston Naming Test
8 
Significant impairment 
 
* Case 2 (GG) only 
1 
not specified; 
2 
McKenna and Warrington (1983); 
3
 Bak, O'Donovan, Xuereb, Boniface, and Hodges (2001); 
4
 Miceli, Silveri, Nocentini, and 
Caramazza (1988); 
5
 Daniele et al. (1994); 
6
 Huber, Poeck, and Willmes (1984); 
7
 60 pictures from Snodgrass and Vanderwart (1980); 
8
 Kaplan, 
Goodglass, and Weintraub (1983) 
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In general, word finding difficulties in PSP “are similar to those of PD patients but they are 
more severe” (Gurd & Hodges, 1997, p. 39). In particular, pronounced deficits on verbal fluency tasks 
have been found consistently. Reflecting the progressive nature of PSP, verbal fluency performance in 
patients with PSP declines over time (Esmonde et al., 1996). In contrast, they tend to perform 
considerably better on confrontation picture naming (e.g. Esmonde et al., 1996; Lebrun et al., 1986; 
Maher et al., 1985; Milberg & Albert, 1989; Robinson et al., 2006). This could suggest that the single 
word production impairments are secondary to executive dysfunction. However, systematic 
investigations of the association between language impairment and executive dysfunction in people 
with PSP are scarce and there is only one published study examining the changes in verbal fluency 
performance over time (Esmonde et al., 1996). 
All the studies reviewed in Table 2 indicate that people with PSP have word finding difficulties, 
but the nature of their poor performance on naming tasks is unclear. For example van der Hurk and 
Hodges (1995) found significant impairment in naming on the Boston Naming Test (BNT) (Kaplan et 
al., 1983). Common error types included semantically related and circumlocutory responses, 
suggesting a breakdown in the retrieval process. On the other hand, Podoll et al. (1991) reported that 
67% of all incorrect responses were visual misperceptions, due to the visuospatial processing 
difficulty related to gaze palsy. Moreover, they found no evidence of naming impairment in 
spontaneous language generation tasks. Therefore, SLPs must conduct a thorough analysis of the error 
responses to determine whether poor performance on naming tasks reflects an impaired retrieval 
process or whether it reflects visuospatial difficulties. In addition, SLPs should assess verb retrieval as 
part of naming assessments because selective action-verb naming is consistently impaired in people 
with PSP (Bak et al., 2006; Cotelli et al., 2006; Daniele et al., 2013; Daniele et al., 1994). No studies 
have been found that report a selective object-noun naming impairment. In clinical practice, therefore, 
the use of naming assessments including both action verbs and nouns could provide a more 
comprehensive picture of a patient’s naming ability.  
3.2.3. Sentence Production 
Table 3 summarizes three studies which have examined sentence production tasks and discourse in 
PSP. Robinson et al. (2006) reported a patient (KAS) with preserved skills in various sentence 
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completion (single words and word pairs) and sentence production tasks (sentences and pictures), 
albeit with long delays. It is a remarkable finding, given that KAS had almost abolished propositional 
language skills. On the other hand, Esmonde et al. (1996) report two patients who produced a 
considerable number of errors, including non-responses and unrelated or bizarre responses, and 
claimed that the errors arose from, among other things, perseverations. With disease progression, 
perseverative errors became more pronounced. In Podoll et al. (1991), six patients completed a 
sentence generation task from the Aachen Aphasia Test (AAT) (Huber et al., 1984). They performed 
significantly worse than the control group. Podoll et al. (1991, p. 1465) suggested that the patients had 
“an inability to convey the information presented in the stimulus pictures”, although the syntactic 
structures they produced were acceptable. 
With respect to discourse-level language production, there are only a limited number of studies 
in patients with PSP. To our knowledge, no studies have exclusively examined functional 
conversations in everyday contexts.  Podoll et al. (1991) reported that there was no evidence of 
agrammatism and concluded that there were no primary aphasic disorders in PSP. They suggested that 
the majority of what appeared to be linguistic deficits were due to the presence of dysarthria. However, 
as stated in the previous sections, we need to interpret this conclusion cautiously, because no formal 
language assessment was used.  Robinson et al. (2006) elicited what they call “topic-based discourse” 
which was essentially a series of three monologues and “interviews”. The participant performed 
worse than healthy controls using the Quantitative Production Analysis (QPA) (Berndt, Wayland, 
Rochon, Saffran, & Schwartz, 2000) and novelty measures. However, they may not be an appropriate 
measure of conversational discourse, because these are designed to capture sentence-level abilities. 
 
Table 3. Sentence production and discourse in progressive supranuclear palsy 
  Assessments used Major findings 
Esmonde et 
al. (1996)* 
Phrase completion Bizarre responses that did not take the prosodic and 
semantic information in the cue or unable to formulate 
a response 
 Picture description Progressive decline of the total number of morphemes 
  Omission of appropriate function words 
  Perseverations 
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  Amsterdam-Nijmegen 
Everyday Language Test
1 
One patient had reduced content, laconic and 
telegraphic responses but the other performed within 
the normal range 
Podoll et al. 
(1991) 
Aachen Aphasia Test
2 
Normal syntactic structures in two patients 
  Short and simple, and sometimes incomplete, 
sentences in four patients 
    No evidence of agrammatism, or WFD 
Robinson et 
al. (2006) 
Phrase completion No errors 
 Sentence construction  No errors or almost at ceiling 
 Topic-based discourse Fewer words and sentences compared to the control 
groups 
  Reduced proportion of novel words and sentences  
  Impaired ability to produce multiple connected 
sentences 
   Perseverations 
 Two interviews (one with 
substantial verbal 
prompting and the other 
with little or no verbal 
prompting) 
Fewer words and sentences; fewer novel words and 
sentences compared to the control groups 
 Significantly worse when no prompting was provided  
 Perseverations 
  Considerably greater proportion of echolalia with 
prompting 
* Patient 1 did not complete the Amsterdam-Nijmegen Everyday Language Test.  
1 
Blomert, Kean, Koster, and Schokker (1994); 
2
 Huber et al. (1984) 
 
 
3.3. Other Impairments: Cognitive impairment and Executive dysfunction 
The evidence appears to be conflicting, but cognitive impairments and executive dysfunction are 
frequently present in patients with PSP. Brown et al. (2010, p. 2389) concluded that “there is little 
reliable or consistent evidence on the prevalence of cognitive impairment or dementia in progressive 
supranuclear palsy”. Nonetheless, Magherini and Litvan (2005) summarized the additional cognitive 
and behavioral aspects of PSP identified since its first description (Steele et al., 1964). Of note in this 
review article was mild-moderately impaired recall and access to stored information, bradyphrenia 
(cognitive slowing), but no deficits in recognition. In their large scale prospective study of people 
with PSP (n = 311) and multiple system atrophy (n = 372), Brown et al. (2010) examined the nature 
of the cognitive impairments. They reported Initiation/Perseveration was the main impairment, 
followed by impaired Memory, then impaired Conceptualization, Construction and lastly Attention, as 
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measured by the Dementia Rating Scale-2 (Jurica, Leitten, & Mattis, 2001). Gerstenecker et al. (2013) 
assessed the cognitive abilities of 200 people with PSP. 85% of their sample were impaired on one or 
more cognitive measures, broadly mirroring the findings of Brown et al. (2010). More recently, 
Kobylecki et al. (2015) retrospectively reviewed the medical files of 62 people with Probable or 
Possible PSP and identified 58% with cognitive or behavioral symptoms as a prominent presenting 
feature. Executive dysfunction was most common, followed by bradyphrenia and inefficient memory 
recall. The exact nature of this inefficient recall was not made clear, but is reportedly related to 
executive and attentional disturbances (see Magherini & Litvan, 2005). 
 
3.4. Speech-Language Pathology Diagnosis? 
We have presented the communication impairments observed in people with PSP. While the motor 
speech impairments are undeniably consistent with mixed dysarthria (hypokinetic, spastic ataxic 
subtypes), it is not clear how to classify the language impairments. One possibility is the primary 
progressive aphasia-plus (PPA+) diagnosis described in Mesulam and Weintraub (2008). PPA+ was 
suggested as a variant of PPA (see Leyton & Hodges, 2014 for a recent review on PPA), in which 
progressive language impairments are accompanied by cognitive and motor deficits. However, 
Mesulam and Weintraub (2008, p. 577) specifically propose that the cognitive and motor deficits 
“arise in the middle or late stages of the disease”. This does not fit with the clinical symptoms seen in 
PSP, as cognitive and motor deficits are apparent from the early stages. A second possibility is that 
the language impairments in PSP are consistent with dynamic aphasia, a subtype of transcortical 
motor aphasia (Berthier, 2000). For example, Robinson, Shallice, and Cipolotti (2005) supported this 
subtypes of dynamic aphasia (pure and mixed) (see also Goldstein, 1948). Pure dynamic aphasia 
refers only to impaired spontaneous language generation with preserved speech and nominal language 
skills, while mixed dynamic aphasia is associated with additional motor, phonological, lexical and/or 
syntactic deficits. Both subtypes have been described in patients with PSP (e.g. mixed subtype in 
Esmonde et al., 1996; pure subtype in Robinson et al., 2006). The diagnosis of transcortical motor 
aphasia would also be consistent with the finding of Daniele et al. (2013) which showed dysfunction 
in the cortical regions anterior or superior to Broca’s area (Goodglass, 1993). 
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However, it is questionable to label the language impairments in PSP a subtype of aphasia 
when there is both executive dysfunction and a pervasive motor speech component involved. Would it 
be possible to designate a new diagnostic label for the communication impairments observed in PSP 
in much the same way as subtypes of PPA have been explicated by Duffy et al (2014)? If this were to 
happen, it would need to encompass the early motor and cognitive symptoms, mild comprehension 
deficits, preserved nominal skills, overall reduction in verbal output and relatively more impaired 
spontaneous language generation that worsens over time plus stuttering, palilalia and echolalia that 
are associated with subcortical as well as cortical damages.  
The primary purpose of this tutorial paper is not to engage in a detailed theoretical discussion 
about the interrelationship between language impairments and cognitive impairments. However, we 
consider it important for SLPs to be aware of the alternative views because this will likely have 
clinical implications and it will guide collaborative management of the language impairment and 
executive dysfunction seen in people with PSP. 
 
4. Considerations for Assessment 
SLPs are most likely to be consulted for the presence of dysarthria for patients with PSP, as dysarthria 
is one of the early and prominent manifestations of PSP. Given the rapid progression of dysarthria in 
PSP (Goetz et al., 2003; Hartelius et al., 2006), some patients may even develop anarthria while 
waiting for speech evaluation (Kluin et al., 2001). Early involvement of SLPs is therefore 
recommended. This involvement will likely include a detailed motor speech assessment of dysarthria 
which can easily be repeated in order to monitor progressive deterioration over time.  
Prominent speech characteristics include imprecise or slurred articulation (Müller et al., 2001). 
Hypophonia, monotonous and slow speech with reduced stress/intonation, reduced respiratory support 
for speech and inappropriate silences are also common features (Hartelius et al., 2006; Skodda et al., 
2011). Due to the similarities in presentation between PSP and PD, there is often a misdiagnosis. In 
order to clarify the speech characteristics of the two conditions and to aid differential diagnosis, Table 
4 below illustrates the major differences.   
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Table 4. Predominant speech characteristics and dysarthria subtypes of progressive supranuclear palsy 
(PSP) and Parkinson’s disease (PD) (adapted from Duffy, 2013 and Müller et al. 2001) 
 PSP PD 
Prominent characteristics 
 Imprecise articulation Monotone 
 Monopitch Vocal flutter 
 Hoarseness Reduced loudness 
 Nasal emission Tremor 
 Hypernasality Breathiness 
 Excess and equal stress Reduced stress 
 Slow rate Rapid rate 
Onset 
 Early onset Later onset 
Subtype 
 Mixed Hypokinetic  
 
Assessing the nature and the extent of language impairments can be a challenge to clinicians 
because of the cognitive impairments/executive dysfunction that are frequently present in patients 
with PSP (Brown et al., 2010; Gerstenecker et al., 2013; Kobylecki et al., 2015; Magherini & Litvan, 
2005). In particular, an impairment in initiation and bradyphrenia can affect performance on time-
limited tasks, such as verbal fluency tasks (Gurd & Hodges, 1997). Therefore, it will be essential for 
SLPs to work with clinical neuropsychologists for a comprehensive and accurate language assessment. 
In addition, there are several other clinical features of PSP which SLPs should take into consideration 
when assessing speech and language impairments in people with PSP. Along with the supranuclear 
gaze palsy, other visual problems (e.g. blurred vision, diplopia) are common in patients with PSP 
(Donker Kaat et al., 2007; Nath et al., 2003). Such difficulties can affect their ability to see and 
process visual information therefore reducing their performance on tasks involving pictures (e.g. 
word-to-picture and sentence-to-picture matching) or written material. Using a book stand to present 
the assessment material at the eye level of patients with PSP may facilitate the assessment procedure. 
Sleep disorders in PSP have also been documented in several studies (e.g. Arnulf et al., 2005; Gama et 
al., 2010; Nomura, Inoue, Takigawa, & Nakashima, 2012), which can lead to fatigue during the day 
and therefore affect their performance on assessments. 
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Although early studies considered language impairments in PSP negligible, our review of the 
literature presents a strong case for the need to consider a language assessment alongside a motor 
speech assessment. We therefore recommend that SLPs should always conduct a language assessment 
with patients with PSP, even if there are no initial signs of language impairment. Table 5 outlines 
possible assessment options for people with PSP. Assessments should be chosen such that they can be 
repeated over time to monitor progression of the condition (Nickels, Taylor, & Croot, 2011). A 
recently developed clinical instrument to monitor the progression of PPA, the Progressive Aphasia 
Severity Scale (PASS) (Sapolsky, Domoto-Reilly, & Dickerson, 2014) may be useful for people with 
PSP. It is important to note that mild impairments, especially in comprehension, will only be revealed 
with a systematic investigation (e.g. Esmonde et al., 1996). In the early stages, sensitive measures are 
recommended to ascertain the presence of a mild language impairment, especially to avoid a ceiling 
effect (Harciarek, Sitek, & Kertesz, 2014). 
Formal assessments should always be supplemented with a spontaneous or conversational 
language task. There are two reasons why this is necessary when assessing language impairment in 
people with PSP. First, SLPs can judge the appropriateness of language production tasks depending 
on the presence of stuttering, echolalia, palilalia and/or cognitive impairments in the language sample. 
For echolalia and palilalia, an analysis of the spontaneous language sample is the only option as there 
are no formal assessments designed to assess them. Second, given the evidence for preserved nominal 
skills and impaired spontaneous language generation (e.g.Robinson et al., 2006), clinical decisions 
regarding the extent of language impairment solely on the basis of standardized language assessments 
may be incomplete. In addition, if SLPs suspect that a semantic memory impairment is contributing to 
poor naming performance the Sydney Language Battery (SYDBAT) (Savage et al., 2013) is 
recommended. This assessment is a picture-based single-word processing assessment. It has four 
subtests, one of which requires selecting (from a choice of four semantically-related items) the one 
picture most closely associated with the target picture.  
Increasingly, SLPs are compelled to consider the wider impact of communication difficulties in 
people with PSP. Previous research (Schrag et al., 2003; Schrag, Selai, Quinn, & Hobart, 2005; 
Schrag et al., 2006) acknowledges the inclusion of patient-reported outcome measures as an 
Page 18 of 30
Ac
ce
pte
d M
an
us
cri
pt
  18 
“important adjunct to clinical data” (Schrag et al., 2005, p. 246). It was on this basis that the PSP-
Quality of Life (PSP-QoL) scale was developed. While only six of the 45 items in the scale are 
directly related to communication, several other items could be influenced by impaired 
communication (e.g. “In the last four weeks have you felt the relationship with your spouse/partner 
has changed?”). Nonetheless, it is recommended that the PSP-QoL be considered, because it is the 
only Quality of Life scale developed specifically people with PSP.  
 
Table 5. Assessment options for people with progressive supranuclear palsy 
Areas of assessment Options 
Motor Speech  
Frenchay Dysarthria Assessment (Enderby & Palmer, 2008) 
Procedure outlined in Duffy (2013) and Freed (2012) 
Language 
 
 
Western Aphasia Battery (Kertesz, 2006) or equivalent language 
battery 
Verbal Fluency 
Boston Naming Test (Kaplan, Goodglass, & Weintraub, 2000) 
Northwestern Assessment of Verbs and Sentences (Thompson, 2011) 
Sydney Language Battery (Savage et al., 2013) or equivalent 
semantic memory assessment 
Other 
Stuttering 
 
 
Symptom 
progression 
Quality of life 
 
Stuttering Severity Instrument (Riley, 2008) 
Procedure outlined in Ringo and Dietrich (1995) and Helm-
Estabrooks (1999) for neurogenic stuttering 
Progressive Aphasia Severity Scale (Sapolsky et al., 2014) 
 
PSP-Quality of Life Scale (Schrag et al., 2006) 
 
5. Considerations for Treatment 
All management decisions must be based on a comprehensive case history, an accurate assessment of 
communication impairments (including co-morbidities), and consideration of pharmacological 
interventions. It is essential that treatment plans are individually tailored and reflect the prognosis, 
motivation and desire of patients (Kinzbrunner, Maluso-Bolton, & Schlecter, 2011). Clinical decisions 
regarding the best treatment approach are difficult to make because there is a significant lack of 
research on effectiveness of treatment for people with PSP. Hanson and Metter (1980) is one of very 
few studies to provide evidence of treatment for dysarthria in PSP. They reported a case of a 59-year-
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old male with PSP, who presented with severe hypokinetic dysarthria. His speech was aided with the 
use of delayed auditory feedback (DAF). This improved his speech rate, loudness and intelligibility 
and the effects were maintained over a period of three months while the device was used daily. 
Another more recent study is that of Countryman, Ramig, and Pawlas (1994), who examined the 
utility of the Lee Silverman Voice Treatment (LSVT
®) in three patients with Parkinson’s Plus 
Syndrome (consistent with Shy-Drager syndrome, multiple system atrophy and PSP). They reported 
that despite the rapid progression (and possible cognitive impairments) seen in the participants, 
LSVT
®
 was successful due to the consistent and simple nature of the intervention. However, this 
finding needs to be regarded with caution, because it includes a single patient with PSP, and was 
carried out over 20 years ago. Furthermore, no subsequent studies have been published using this 
technique. 
In the absence of other published studies, we propose the framework illustrated in Figure 1 
which conceptualizes treatment approaches. Due to the heterogeneity of the condition, this list of 
approaches is not exhaustive. Rather, it is intended to be the starting point for SLPs when considering 
how to manage patients with PSP. Of particular importance is the distinction between facilitation 
approaches (which directly target the motor speech and/or language impairments) and compensation 
approaches (which address the communication environment). Management plans should consider the 
progressive nature of PSP and be aware of its impact on both the patient and his/her family members. 
Given the prognosis, treatment may be best achieved in conjunction with other health professionals 
who specialize in palliative approaches. Augmentative and alternative communication support should 
be considered from the early stages. However, SLPs should not simply choose a compensation 
approach over facilitation in treatment, because people with PSP could still benefit from impairment-
based therapy (Countryman et al., 1994).  
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Figure 1. Conceptualization of treatment for people with progressive supranuclear palsy 
* the evidence for these therapy techniques is based on two single cases of people with PSP 
 
Central to both facilitation and compensation illustrated in Figure 1 is improving quality of life 
for people with PSP and their family members. Collaboration between caregivers as well as other 
medical professionals, particularly in end-of-life care, can contribute to improving quality of life 
(Lorenz et al., 2008). Raising awareness of the presence of communication impairments in people 
with PSP is pertinent in improving their quality of life. For family members, specific intervention and 
education can relieve their burden and lead to effective overall management of people with PSP 
(Schrag et al., 2003). For other healthcare professionals, the role of SLPs should be promoted, 
because SLPs may not have a prominent role in the management of patients with PSP and may not 
even be involved in the early stages. This is particularly important as Schrag et al. (2003) found that 
communication difficulty was among the most relevant issues for quality of life in people with PSP. 
 
6. Conclusion 
This article has reviewed communication impairments in patients with PSP and provides clinical 
guidelines for assessment and treatment. The presence of dysarthria is almost a universal finding and 
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language impairments may be more common than initially thought. It has been and still is a subject of 
debate as to whether the language impairments are consistent with aphasia (and/or one of its subtypes) 
or secondary to executive dysfunction. Either way, patients with PSP do have communication 
impairments which should justify the active involvement of SLPs in assessment and treatment. 
Furthermore, the possibility of establishing a new diagnostic description and label for the 
communication impairments seen in people with PSP has been postulated. 
The motivation for this tutorial article was the lack of SLP-specific guidelines for assessment 
and management of communication impairments in people with PSP. Although we have provided a 
clinical description, it is evident from the literature that there are areas requiring further research in 
order to establish evidence-based management for people with PSP.  
We have suggested some communication assessment tools based on the current literature. 
However, there is no assessment specifically designed to monitor the progression of communication 
impairments in people with PSP. Given the important role SLPs undertake in managing people with 
progressive neurological conditions, such as PSP, it is worth considering the development of an 
assessment tool sufficiently sensitive to detect mild language impairment at an early stage and to 
measure change over time (including the impact of medications). 
There are only two studies reporting treatment for people with PSP, both of which focused on 
motor speech impairment, with no studies reporting treatment for the management of language 
difficulties. Therefore, there is a need for a more systematic investigation of language difficulties, 
beyond the single word level and possible treatment approaches. Carefully designed prospective 
longitudinal studies will contribute to understanding the course of disease progression thereby 
informing SLP management approaches.  
Although PSP is relatively rare, communication impairments observed in people with PSP are 
more severe and worsen more rapidly than other progressive neurological conditions. It is worth 
considering the establishment of an international effort to devise best practice guidelines for SLPs 
which can enable early involvement, accurate assessment and effective intervention. 
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